PIN37 COST-UTILITY OF ALFAPEGINTERFERON-2A (40 KD) IN CO-INFECTED PATIENTS IN THE PRIVATE HEALTH CARE SYSTEM IN BRAZIL
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65544-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65544-1/fulltext
Section Title :
Section Order :
703
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65544-1&doi=10.1016/S1098-3015(10)65544-1